Erlend Finvold • 1986 • Ås • 10 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
F FINVOLD MANAGEMENT AS	Managing Director/CEO	40,750	6,695,320	100 % directly
F FINVOLD PROSJEKT CONSULT AS	Managing Director/CEO	4,493,296	2,313,454	50 % indirectly
F FINVOLD HOLDING AS	Managing Director/CEO	-	15,074,697	50 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
F FINVOLD MANAGEMENT AS	Chairman	40,750	6,695,320	100 % directly
C COSMOTECH AS	Chairman	-	3,638	50 % indirectly
A ADVANCE EDGE HOLDING AS	Chairman	-	115,838	50 % indirectly
F FINVOLD PROSJEKT CONSULT AS	Board Member	4,493,296	2,313,454	50 % indirectly
F FINVOLD HOLDING AS	Board Member	-	15,074,697	50 % indirectly
C CAREXPO AS Closed	Board Member	7,499,539	740,529	33.33 % indirectly
S SOMMERRO LØKKE AS	Chairman	-	-448,283	-

Last update: Aug 18, 2023

Related industries2

Direct relationships5

RG
Rune Geir Finvold1957
FINVOLD MANAGEMENT AS, FINVOLD PROSJEKT CONSULT AS, FINVOLD HOLDING AS
NO
Noah Ondigo Kabir1984
COSMOTECH AS, ADVANCE EDGE HOLDING AS
OJ
Olav Jarle Sandven1955
SOMMERRO LØKKE AS
TA
Tom Anders Melheim1973
CAREXPO AS
MK
Marko Kovacevic1984
CAREXPO AS

Shares owned by Erlend Neuenkirchen Finvold

Name	Share class	Total operating income	Total equity	Share
F FINVOLD MANAGEMENT AS	Ordinære aksjer	40,750	6,695,320	100 % directly
C COSMOTECH AS		0	3,638	50 % indirectly
A ADVANCE EDGE HOLDING AS		0	115,838	50 % indirectly
F FINVOLD PROSJEKT CONSULT AS		4,493,296	2,313,454	50 % indirectly
F FINVOLD HOLDING AS		0	15,074,697	50 % indirectly
C CAREXPO AS Closed		7,499,539	740,529	33.33 % indirectly
P PROBIOMA GUT HEALTH AS		61,000	-513,506	9.09 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025